Edition:
India

Retrophin Inc (RTRX.OQ)

RTRX.OQ on NASDAQ Stock Exchange Global Market

25.28USD
22 Jan 2018
Change (% chg)

-- (--)
Prev Close
$25.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
101,396
52-wk High
$26.43
52-wk Low
$15.57

Select another date:

Mon, Jan 8 2018

BRIEF-Retrophin Expects Total Net Product Sales Of Approximately $155 Million​ In 2018

* ‍FOR FISCAL YEAR 2017, COMPANY EXPECTS TOTAL NET PRODUCT SALES OF APPROXIMATELY $155 MILLION​

BRIEF-Retrophin And Censa Pharmaceuticals Enter Into Strategic Collaboration To Advance Cnsa-001

* RETROPHIN AND CENSA PHARMACEUTICALS ENTER INTO STRATEGIC COLLABORATION TO ADVANCE CNSA-001 FOR THE TREATMENT OF PHENYLKETONURIA (PKU)

BRIEF-Retrophin Enters Into Future Acquisition Right, Joint Development Agreement With Censa Pharma

* RETROPHIN SAYS ON DEC 16, CO ENTERED INTO FUTURE ACQUISITION RIGHT, JOINT DEVELOPMENT AGREEMENT WITH CENSA PHARMA - SEC FILING

BRIEF-Retrophin reports third quarter 2017 financial results

* Q3 earnings per share view $-0.25 -- Thomson Reuters I/B/E/S

BRIEF-Retrophin reports Q2 loss per share $0.34

* Q2 earnings per share view $-0.22 -- Thomson Reuters I/B/E/S

BRIEF-Retrophin commences patient dosing in international, registrational phase 3 trial of RE-024 in PKAN

* Retrophin commences patient dosing in international, registrational phase 3 trial of re-024 in pkan

Select another date: